Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization

Pao Pao Yang, Eagle Yi Kung Huang, Geng Chang Yeh, Pao Luh Tao

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Methamphetamine (MA) is well known as a potent CNS stimulant, which produces strong rewarding and behavioral sensitization after repeated administration. In the present study, we investigated whether co-administration of dextromethorphan (DM) with MA could suppress these effects induced by acute and chronic MA treatment. The conditioned place preference (CPP) test was used to examine the rewarding/drug seeking effects and locomotor and stereotypic activities were measured to investigate behavioral sensitization induced by chronic MA. Our results revealed that co-administration of DM (20 mg/kg, ip) with MA (2 mg/kg, ip) almost completely abolished the MA-induced CPP and behavioral sensitization. Furthermore, both of the acute and chronic MA could result in an increase of dopamine (DA) turnover rate in the NAc and mPFC. The acute effects of MA on DA turnover rate could be attenuated by the co-administration of DM in both regions. The chronic effect of MA on DA turnover rate in the mPFC was also attenuated by the co-administration of DM. These results suggest that the effect of DM on blocking MA-induced rewarding and behavioral sensitization may be related to its effect on inhibiting the activity of DA neurons projected to mPFC and/or NAc.

Original languageEnglish
Pages (from-to)695-702
Number of pages8
JournalJournal of Biomedical Science
Volume13
Issue number5
DOIs
Publication statusPublished - Sep 2006

Fingerprint

Dextromethorphan
Methamphetamine
Dopamine
Dopaminergic Neurons
Locomotion
Neurons

Keywords

  • Behavioral sensitization
  • Dextromethorphan
  • Dopamine
  • Methamphetamine
  • Nucleus accumbens
  • Rewarding
  • Ventral tegmental area

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization. / Yang, Pao Pao; Huang, Eagle Yi Kung; Yeh, Geng Chang; Tao, Pao Luh.

In: Journal of Biomedical Science, Vol. 13, No. 5, 09.2006, p. 695-702.

Research output: Contribution to journalArticle

Yang, Pao Pao ; Huang, Eagle Yi Kung ; Yeh, Geng Chang ; Tao, Pao Luh. / Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization. In: Journal of Biomedical Science. 2006 ; Vol. 13, No. 5. pp. 695-702.
@article{dd0a8ff4d6b74a08a4a2f971d94a7b60,
title = "Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization",
abstract = "Methamphetamine (MA) is well known as a potent CNS stimulant, which produces strong rewarding and behavioral sensitization after repeated administration. In the present study, we investigated whether co-administration of dextromethorphan (DM) with MA could suppress these effects induced by acute and chronic MA treatment. The conditioned place preference (CPP) test was used to examine the rewarding/drug seeking effects and locomotor and stereotypic activities were measured to investigate behavioral sensitization induced by chronic MA. Our results revealed that co-administration of DM (20 mg/kg, ip) with MA (2 mg/kg, ip) almost completely abolished the MA-induced CPP and behavioral sensitization. Furthermore, both of the acute and chronic MA could result in an increase of dopamine (DA) turnover rate in the NAc and mPFC. The acute effects of MA on DA turnover rate could be attenuated by the co-administration of DM in both regions. The chronic effect of MA on DA turnover rate in the mPFC was also attenuated by the co-administration of DM. These results suggest that the effect of DM on blocking MA-induced rewarding and behavioral sensitization may be related to its effect on inhibiting the activity of DA neurons projected to mPFC and/or NAc.",
keywords = "Behavioral sensitization, Dextromethorphan, Dopamine, Methamphetamine, Nucleus accumbens, Rewarding, Ventral tegmental area",
author = "Yang, {Pao Pao} and Huang, {Eagle Yi Kung} and Yeh, {Geng Chang} and Tao, {Pao Luh}",
year = "2006",
month = "9",
doi = "10.1007/s11373-006-9096-4",
language = "English",
volume = "13",
pages = "695--702",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "5",

}

TY - JOUR

T1 - Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization

AU - Yang, Pao Pao

AU - Huang, Eagle Yi Kung

AU - Yeh, Geng Chang

AU - Tao, Pao Luh

PY - 2006/9

Y1 - 2006/9

N2 - Methamphetamine (MA) is well known as a potent CNS stimulant, which produces strong rewarding and behavioral sensitization after repeated administration. In the present study, we investigated whether co-administration of dextromethorphan (DM) with MA could suppress these effects induced by acute and chronic MA treatment. The conditioned place preference (CPP) test was used to examine the rewarding/drug seeking effects and locomotor and stereotypic activities were measured to investigate behavioral sensitization induced by chronic MA. Our results revealed that co-administration of DM (20 mg/kg, ip) with MA (2 mg/kg, ip) almost completely abolished the MA-induced CPP and behavioral sensitization. Furthermore, both of the acute and chronic MA could result in an increase of dopamine (DA) turnover rate in the NAc and mPFC. The acute effects of MA on DA turnover rate could be attenuated by the co-administration of DM in both regions. The chronic effect of MA on DA turnover rate in the mPFC was also attenuated by the co-administration of DM. These results suggest that the effect of DM on blocking MA-induced rewarding and behavioral sensitization may be related to its effect on inhibiting the activity of DA neurons projected to mPFC and/or NAc.

AB - Methamphetamine (MA) is well known as a potent CNS stimulant, which produces strong rewarding and behavioral sensitization after repeated administration. In the present study, we investigated whether co-administration of dextromethorphan (DM) with MA could suppress these effects induced by acute and chronic MA treatment. The conditioned place preference (CPP) test was used to examine the rewarding/drug seeking effects and locomotor and stereotypic activities were measured to investigate behavioral sensitization induced by chronic MA. Our results revealed that co-administration of DM (20 mg/kg, ip) with MA (2 mg/kg, ip) almost completely abolished the MA-induced CPP and behavioral sensitization. Furthermore, both of the acute and chronic MA could result in an increase of dopamine (DA) turnover rate in the NAc and mPFC. The acute effects of MA on DA turnover rate could be attenuated by the co-administration of DM in both regions. The chronic effect of MA on DA turnover rate in the mPFC was also attenuated by the co-administration of DM. These results suggest that the effect of DM on blocking MA-induced rewarding and behavioral sensitization may be related to its effect on inhibiting the activity of DA neurons projected to mPFC and/or NAc.

KW - Behavioral sensitization

KW - Dextromethorphan

KW - Dopamine

KW - Methamphetamine

KW - Nucleus accumbens

KW - Rewarding

KW - Ventral tegmental area

UR - http://www.scopus.com/inward/record.url?scp=33749343488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749343488&partnerID=8YFLogxK

U2 - 10.1007/s11373-006-9096-4

DO - 10.1007/s11373-006-9096-4

M3 - Article

C2 - 16865411

AN - SCOPUS:33749343488

VL - 13

SP - 695

EP - 702

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 5

ER -